Four integrated technologies for biologics developability assessment

December 13, 2022

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics.

Combine sizing and stability information to gain valuable insight into the viability of your protein-based biologic candidates, enabling you to select the best ones for further development.

The technologies inside the Prometheus Panta provide high-quality information about your candidates’ purity, size, thermal stability, and aggregation, which enables better pipeline decisions.

Learn more about how Prometheus Panta helps biologics researchers.

Previous
Why Dr. Elsa Wagner from Pierre Fabre chose Prometheus Panta for mAbs developability assessment
Why Dr. Elsa Wagner from Pierre Fabre chose Prometheus Panta for mAbs developability assessment

Read why scientist Dr. Elsa Wagner chose the Prometheus Panta instrument with simultaneous measurements of ...

Up next
Select the best biologics candidates with high-quality, multi-parameter stability characterization
Select the best biologics candidates with high-quality, multi-parameter stability characterization

Ready to tackle your challenging stability characterizations?

Discover tools